Why You’ve Never Heard of the Company Behind the Abortion Pill
- Danco doesn’t disclose CEO, board or investors due to threats
- Texas ruling could pull mifepristone from US marketplace
This article is for subscribers only.
As far as drug companies go, abortion-pill maker Danco Laboratories is all but anonymous. It has fewer than 20 employees, uses a P.O. Box to avoid sharing its headquarters address and isn’t listed on any public exchanges.
Now its sole product, the abortion pill mifepristone, has been thrust into the national spotlight after a federal judge in Texas ruled that the US Food and Drug Administration shouldn’t have approved it more than two decades ago. An appeals court said Wednesday the pill can stay on the market with extensive restrictions while it reviews the decision, but that’s hardly a win for Danco. The legal battles are ongoing and the consequences could be severe.